These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23303357)

  • 21. Hypertension, beta-adrenoceptor blocking agents and exercise.
    van Baak MA
    Int J Sports Med; 1994 Apr; 15(3):112-5. PubMed ID: 7911791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 23. Digital arterial tone in hypertensive subjects treated with cardioselective and non-selective beta-adrenoreceptor blocking agents.
    Nielsen PE; Nielsen SL
    Dan Med Bull; 1981 Apr; 28(2):76-8. PubMed ID: 6113917
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adrenergic beta receptor blockaders in arterial hypertension].
    Rodríguez-Navarro CQ; Maceira Cruz B; Fernández Andrade C; Ortega Amaya J; Garcia de Pesquera F; López Solbes R; Castilla Jiménez J; Mateos Aguilar J
    Rev Clin Esp; 1975 Nov; 139(4):345-51. PubMed ID: 1828
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamic chronosensitivity to metopress-retard in patients with stage ii hypertension].
    Zaslavskaia RM; Zhumabaeva TN; Zhamankulov KA; Teĭblium MM
    Klin Med (Mosk); 1998; 76(10):42-4. PubMed ID: 9865017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 29. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
    Basile J
    J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of different beta-receptor antagonists on handgrip in essential hypertension.
    Fogari R; Marchesi E; Bellomo G; Parini A; Corradi L
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age dependency of blood pressure response to antihypertensive treatment: some methodological considerations and observations on five beta-adrenoceptor antagonists under different experimental conditions.
    Man in 't Veld AJ; van den Meiracker AH; Schalekamp MA
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S93-9. PubMed ID: 2469907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possibilities in the treatment of hypertension with beta-blockaders].
    Tuckman J; Flury W
    Schweiz Rundsch Med Prax; 1972 Sep; 61(36):1107-9. PubMed ID: 4404690
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood pressure variability in patients on beta-blockers.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):25-6. PubMed ID: 14620
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of orally administered beta-adrenergic blockers and calcium-channel blockers on the intraocular pressure of patients with treated hypertension.
    Suzuki R; Hanada M; Fujii H; Kurimoto S
    Ann Ophthalmol; 1992 Jun; 24(6):220-3. PubMed ID: 1359825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P
    Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary protection with beta-blockers in the treatment of hypertension.
    Coope J
    Drugs Exp Clin Res; 1990; 16(3):129-31. PubMed ID: 1974840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.